Enoblituzumab
Humanized (from mouse) | |
---|---|
Target | B7-H3 |
Clinical data | |
Other names | MGA271 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6474H9990N1726O2030S42 |
Molar mass | 145829.71 g·mol−1 |
Enoblituzumab is a monoclonal antibody designed for the treatment of cancer.B7-H3, a member of the B7 family of immune regulators.
This drug was developed by MacroGenics, Inc.